In vitro, PF-06873600 potently suppressed RB1 phosphorylation and inhibited cancer cell proliferation, while in vivo it achieved robust tumor regression, including approximately 90% reduction in OVCAR3 ovarian tumor xenografts at a single 50 mg/kg oral dose (Freeman-Cook K. et al., 2021). The gene discussed is RB1; the disease is neoplasm.